![Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards](https://mma.prnewswire.com/media/1179400/Abbott_FreeStyle_Libre_2_Sensor.jpg?p=facebook)
Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
![New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life](https://mma.prnewswire.com/media/1915186/FreeStyle_Libre_2.jpg?p=facebook)
New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life
![PDF) A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol PDF) A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol](https://i1.rgstatic.net/publication/355084367_A_comparison_of_FreeStyle_Libre_2_to_self-monitoring_of_blood_glucose_in_children_with_type_1_diabetes_and_sub-optimal_glycaemic_control_a_12-week_randomised_controlled_trial_protocol/links/615cf325c04f5909fd8584e3/largepreview.png)
PDF) A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol
![Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott's FreeStyle Libre 3 - Ypsomed - Group Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott's FreeStyle Libre 3 - Ypsomed - Group](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Loop_Libre_camAPS_V3_YpsoPump_Media_de-DE.jpg)
Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott's FreeStyle Libre 3 - Ypsomed - Group
![FreeStyle Libre 2 Sensor | Shop the latest CGMs, catheters, ostomy bags, and more from all the leading brands. FreeStyle Libre 2 Sensor | Shop the latest CGMs, catheters, ostomy bags, and more from all the leading brands.](http://joinbetter.com/cdn/shop/products/Libre2Sensors_1200x1200.png?v=1662557460)
FreeStyle Libre 2 Sensor | Shop the latest CGMs, catheters, ostomy bags, and more from all the leading brands.
![FreeStyle Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service - iData Research FreeStyle Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service - iData Research](https://idataresearch.com/wp-content/uploads/2017/10/kit_modele_freestyle_libre22.jpg)
FreeStyle Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service - iData Research
![Sensors | Free Full-Text | Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Sensors | Free Full-Text | Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective](https://www.mdpi.com/sensors/sensors-21-06131/article_deploy/html/images/sensors-21-06131-g001.png)
Sensors | Free Full-Text | Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective
![Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes - Apr 27, 2022 Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes - Apr 27, 2022](https://mma.prnewswire.com/media/1805579/Abbott_CamDiab_Ypsomed.jpg?p=original)
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes - Apr 27, 2022
![Kidney and Dialysis | Free Full-Text | What Nephrologists Should Know about the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Patients on Chronic Hemodialysis Kidney and Dialysis | Free Full-Text | What Nephrologists Should Know about the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Patients on Chronic Hemodialysis](https://www.mdpi.com/kidneydial/kidneydial-02-00042/article_deploy/html/images/kidneydial-02-00042-g001.png)